X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (957) 957
humans (883) 883
double-blind (559) 559
multiple sclerosis (391) 391
controlled phase-3 trial (342) 342
placebo-controlled phase-3 (330) 330
male (317) 317
female (288) 288
placebo-controlled trial (276) 276
clinical neurology (275) 275
oncology (253) 253
randomized controlled trials as topic (242) 242
treatment outcome (233) 233
middle aged (206) 206
adult (205) 205
pharmacology & pharmacy (200) 200
care and treatment (176) 176
efficacy (167) 167
chemotherapy (163) 163
clinical trials (163) 163
drug therapy (163) 163
phase-3 trial (161) 161
phase-3 (153) 153
safety (152) 152
analysis (149) 149
neurosciences (145) 145
aged (141) 141
open-label (140) 140
multiple sclerosis - drug therapy (133) 133
therapy (133) 133
research (130) 130
cancer (126) 126
medicine, general & internal (125) 125
oral bg-12 (125) 125
dimethyl fumarate (124) 124
patients (124) 124
alemtuzumab (121) 121
medicine & public health (119) 119
randomized controlled-trial (119) 119
controlled phase-3 (117) 117
immunology (115) 115
animals (113) 113
multiple sclerosis, relapsing-remitting - drug therapy (112) 112
immunosuppressive agents - therapeutic use (109) 109
neurology (105) 105
review (105) 105
multicenter (104) 104
glatiramer acetate (98) 98
prostate cancer (91) 91
metastasis (87) 87
survival analysis (87) 87
progressive multifocal leukoencephalopathy (85) 85
disease progression (84) 84
quality-of-life (81) 81
risk factors (79) 79
antineoplastic agents - therapeutic use (78) 78
studies (78) 78
interferon beta-1a (77) 77
health aspects (75) 75
medical research (74) 74
interferon (73) 73
internal medicine (73) 73
natalizumab (73) 73
oral fingolimod (73) 73
antibodies, monoclonal, humanized - therapeutic use (72) 72
antineoplastic combined chemotherapy protocols - therapeutic use (72) 72
monoclonal antibodies (72) 72
controlled-trial (70) 70
abiraterone acetate (69) 69
quality of life (69) 69
urology & nephrology (69) 69
disease (68) 68
disease-free survival (68) 68
trial (68) 68
survival (66) 66
abridged index medicus (65) 65
antibodies, monoclonal - therapeutic use (65) 65
clinical trials, phase iii as topic (65) 65
medicine, research & experimental (65) 65
oral teriflunomide (65) 65
usage (64) 64
multiple-sclerosis (63) 63
young adult (63) 63
aged, 80 and over (61) 61
immunotherapy (60) 60
double-blind method (58) 58
immunologic factors - therapeutic use (58) 58
fingolimod (57) 57
magnetic resonance imaging (55) 55
retrospective studies (55) 55
prognosis (54) 54
surgery (54) 54
clinical trials as topic (53) 53
intramuscular interferon (53) 53
meta-analysis (53) 53
disease-modifying therapies (52) 52
docetaxel (52) 52
interferon-beta (52) 52
experimental autoimmune encephalomyelitis (49) 49
patient outcomes (49) 49
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE REVIEWS CLINICAL ONCOLOGY, ISSN 1759-4774, 09/2016, Volume 13, Issue 9, pp. 535 - 535
In a recent study, the addition of olaratumab to doxorubicin chemotherapy for patients with soft-tissue sarcoma resulted in prolongation of progression-free... 
ONCOLOGY | CONTROLLED PHASE-3 TRIAL
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 22, pp. 2244 - 2250
PurposeARCHER 1050, a randomized, open-label, phase III study of dacomitinib versus gefitinib in treatment-naive patients with advanced non-small-cell lung... 
1ST-LINE TREATMENT | CONTROLLED-TRIAL | MULTICENTER | ONCOLOGY | ADENOCARCINOMA | PHASE-3 TRIAL | OPEN-LABEL | AFATINIB | INHIBITOR | CHEMOTHERAPY | ERLOTINIB
Journal Article
Neurology, ISSN 0028-3878, 11/2016, Volume 87, Issue 19, pp. 1966 - 1967
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
Journal Article
mAbs, ISSN 1942-0862, 02/2017, Volume 9, Issue 2, pp. 167 - 181
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2017, Volume 15, Issue 5.5, pp. 733 - 736
Soft tissue sarcomas comprise multiple histologic subtypes, occur at a number of anatomic sites, and require individualized treatment. Over the past 5 years, 4... 
1ST-LINE TREATMENT | EFFICACY | ONCOLOGY | SAFETY | DOXORUBICIN | CONTROLLED PHASE-3 TRIAL
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2018, Volume 24, Issue 21, pp. 5233 - 5238
Purpose: The prognosis for patients with refractory softtissue sarcoma (STS) is dismal. Anlotinib has previously shown antitumor activity on STS in preclinical... 
DOXORUBICIN-BASED CHEMOTHERAPY | 1ST-LINE TREATMENT | LIPOSARCOMA | ONCOLOGY | 2-STAGE DESIGNS | CLINICAL-TRIALS | DOUBLE-BLIND | CONTROLLED PHASE-3 TRIAL | OPEN-LABEL | TRABECTEDIN | PART SARCOMA
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 10/2017, Volume 167, Issue 8, pp. JC43 - JC43
Journal Article
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, ISSN 1744-666X, 01/2013, Volume 9, Issue 1, pp. 9 - 9
Journal Article
Multiple Sclerosis and Related Disorders, ISSN 2211-0348, 01/2018, Volume 19, pp. 6 - 7
Journal Article
Journal Article
IMMUNOTHERAPY, ISSN 1750-743X, 01/2013, Volume 5, Issue 1, pp. 6 - 7
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 10/2017, Volume 177, Issue 4, pp. 1033 - 1042
Summary Background Secukinumab has demonstrated significant efficacy with a good safety profile through 1 year in plaque psoriasis. Given the chronic nature of... 
CONTROLLED-TRIAL | USTEKINUMAB | SEVERE PLAQUE PSORIASIS | PHASE-3 TRIAL | BRODALUMAB | USABILITY | ARTHRITIS | LIFE | DERMATOLOGY | Skin diseases | Inflammation | Safety | Psoriasis | Quality of life
Journal Article
DIABETES CARE, ISSN 0149-5992, 03/2018, Volume 41, Issue 3, pp. 613 - 619
OBJECTIVE ITCA 650 is a subdermal osmotic mini-pump that continuously delivers exenatide subcutaneously for 3-6 months. The efficacy, safety, and tolerability... 
METFORMIN | GLYCEMIC CONTROL | CONTINUOUS SUBCUTANEOUS DELIVERY | ADD-ON | EXENATIDE | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | PHASE-3 TRIAL | OPEN-LABEL | PLACEBO-CONTROLLED TRIAL | MEDICATION ADHERENCE
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2018, Volume 197, Issue 1, pp. 22 - 37
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.